InvestSMART

Anagenics Limited (ASX:AN1)

ALERT: Price-sensitive ASX Announcement for AN1
Current share price for AN1 : $0.006 0 (0%)+
Announcement
Release
30 Jul 2026 10:17AM
Price at Release
$0.006
Full Release
download
Summary
Anagenics Limited reported an improved operational performance for Q4 FY2026, with expectations of announcing its maiden full-year profit for FY2026, pending audit results. Although the company experienced operating cash outflows of $0.08 million during this quarter, the trading performance was positive. The reduction in payable and borrowings from $2 million to $0.2 million was achieved, signifying a successful restructuring effort. BLC Cosmetics, a subsidiary, has been restructured and is expanding its product portfolio. The company generated $446k in royalty revenue from the YSB product line, with total invoiced royalty revenue of $1.3 million for the year ending 30 June 2026. The appendix includes a detailed quarterly cash flow report as required by the ASX listing rules.
Key Points
  • Anagenics Limited anticipates its first full-year profit for FY2026, subject to audit.
  • Operating cash outflow for 4Q26 was $0.08 million.
  • Reduction in payables and borrowings from $2 million to $0.2 million.
  • BLC Cosmetics successfully restructured and expanding its product range.
  • Royalty revenue of $446k from YSB product line in 4Q26.
  • Total YSB royalty revenue of $1.3 million for the year ending 30 June 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.